Status:

RECRUITING

Shoulder Impingement Syndrome and Graded Motor Imagery

Lead Sponsor:

Nuray Alaca

Conditions:

Shoulder Pain

Shoulder Impingement Syndrome

Eligibility:

All Genders

20-50 years

Phase:

NA

Brief Summary

Graded motor imagery (GMI): used successfully in chronic, complex and painful clinical conditions accompanied by many pain and movement problems; It is a treatment, education and rehabilitation proces...

Eligibility Criteria

Inclusion

  • 20-50 years of age with complaints of shoulder pain in the anterio-lateral region lasting more than 6 weeks, with a positive Neer impingement test and/or a positive Hawkins-Kennedy test
  • Additionally, patients must have at least one of the symptoms listed. These symptoms are: painful arch on active shoulder elevation, pain with resisted shoulder external rotation in abduction at 90°, and a positive empty can test.

Exclusion

  • Having had a steroid injection into the shoulder within the last 3 months
  • Previous surgery on the neck, thoracic spine or shoulder
  • Red flags (e.g. tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis, resting blood pressure greater than 140/90 mmHg, history of long-term steroid use)
  • History of shoulder dislocation, subluxation, fracture, adhesive capsulitis, frozen shoulder, or cervical or thoracic surgery
  • History of full-thickness rotator cuff tear
  • History of cervical disc herniation in the last 6 weeks
  • History of breast cancer on the involved side
  • Isolated acromioclavicular joint pathology (i.e., pain directly localized over the acromioclavicular joint).
  • Signs of cervical radiculopathy, radiculitis, or referred pain originating from the cervical spine
  • Receiving treatment for shoulder pain in the last 3 months
  • Being currently pregnant (Dunning, 2022)
  • Scoring ≤24 on the Standardized Mini Mental Test was determined.

Key Trial Info

Start Date :

October 13 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 13 2025

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06092502

Start Date

October 13 2023

End Date

December 13 2025

Last Update

July 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nuray ALACA

Istanbul, Turkey (Türkiye), +90